Intestinal Obstruction: There are reports linking Ozempic to blockages in the intestines, a potentially life-threatening condition, highlighting concerns about the drugs effects on gut motility and safety
Preclinical studies have demonstrated the efficacy of short-acting and the more recent long-acting GLP-1 receptor agonists to reduce alcohol self-administration, relapse-like behaviors, and binge drinking in rodent models (Egecioglu et al
That is, the ADA recommends that one of these agents be considered as add-on therapy irrespective of the need for glucose lowering
Almost every dose produces a decimal that does not align cleanly with syringe markings
It was first FDA-approved in 2010 under the brand name Egrifta for HIV-associated lipodystrophy, a condition causing excess visceral fat accumulation
Check us out on EarthSnap, a free app brought to you by Eric Ralls and Earth.com